DEF 14A: Expion360 Seeks Stockholder Approval for Reverse Stock Split, Share Reduction, and Warrant Issuance

Expion360 is asking stockholders to approve a reverse stock split, a reduction in authorized shares, and the issuance of warrants at its upcoming annual meeting.

Summary

• Expion360 Inc. is holding its 2024 Annual Meeting of Stockholders on September 27, 2024, to vote on several key proposals.
• The proposals include the election of five directors, ratification of the appointment of M&K CPAS, PLLC as the independent registered public accounting firm, and approval of a reverse stock split.
• The reverse stock split would be within a range of 1-for-50 to 1-for-100, with the exact ratio determined by the Board of Directors.
• Stockholders will also vote on reducing the number of authorized shares of capital stock by 20% to 80%, contingent on the reverse stock split being approved and implemented.
• Additionally, the company seeks approval for the issuance of Series A and Series B warrants in connection with a recent securities offering consummated on August 8, 2024.
• The Board of Directors recommends voting in favor of all proposals.

Sentiment

Score: 5

Explanation: The document is neutral in tone, primarily presenting factual information about the proposals to be voted on at the annual meeting. The inclusion of both potential benefits and risks associated with the proposals contributes to the neutral sentiment.

Positives

• The reverse stock split aims to increase the per share trading price to regain compliance with Nasdaq's minimum bid price requirement.
• A higher stock price could improve marketability to institutional investors and attract analyst coverage.
• The company believes a higher stock price could help attract and retain employees and other service providers.

Negatives

• There is no guarantee that the reverse stock split will increase the stock price or maintain Nasdaq listing compliance.
• The reverse stock split could decrease trading liquidity due to the reduced number of outstanding shares.
• If the stock price declines after the reverse stock split, the percentage decline could be greater.
• Existing stockholders will experience dilution in their ownership interests as a result of the potential issuance of shares of Common Stock upon exercise of the Series A and B Warrants.

Risks

• Failure to regain compliance with Nasdaq's minimum bid price requirement could lead to delisting.
• Delisting could make it more difficult for investors to dispose of or obtain accurate quotations for the stock.
• The company may face challenges in raising additional capital if the stock price remains low.
• The increased proportion of unissued authorized shares to issued shares could, under certain circumstances, be construed as having an anti-takeover effect.

Future Outlook

The company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made.

Industry Context

The document does not provide specific details on how this announcement relates to broader industry trends or competitors.

Related Party Transactions

• The Company issued an unsecured promissory note owed to H. Porter Burns, a holder of approximately 0.7% of our outstanding capital stock as of August 5, 2024, in the principal amount of $500,000.
• The Porter Burns Note requires monthly interest-only payment at 10% per annum.
• The Porter Burns Note had an original maturity date of August 1, 2023, but was extended to mature on September 1, 2024 by agreement dated July 2, 2024.
• As of August 8, 2024, the Porter Burns Note was paid in full.
• On January 1, 2019, the Company issued an unsecured promissory note owed to H. Porter Burns, a holder of approximately 0.7% of our outstanding capital stock as of August 5, 2024, in the principal amount of $62,500.
• The 1/1/19 Porter Burns Note requires monthly interest-only payment at 10% per annum.
• As of December 31, 2023, the 1/1/19 Porter Burns Note was paid in full.
• On January 1, 2019, the Company issued an unsecured promissory note owed to James Yozamp, Jr., a beneficial owner of approximately 7.3% of our outstanding capital stock as of August 5, 2024, in the principal amount of $62,500.
• The 1/1/19 James Yozamp Note requires monthly interest only payments at 10% per annum.
• The 1/1/19 James Yozamp Note matures on January 29, 2024.
• As of January 29, 2024, the 1/1/19 James Yozamp Note was paid in full.
• On December 31, 2019, the Company issued an unsecured promissory note owed to James Yozamp, Jr., a holder of approximately 7.3% of our outstanding capital stock as of August 5, 2024, in the principal amount of $200,000.
• The James Yozamp Note requires monthly interest only payments at 10% per annum.
• The James Yozamp Note matures on December 31, 2024.
• As of August 8, 2024, the James Yozamp Note was paid in full.
• On January 1, 2019, the Company issued an unsecured promissory note to John Yozamp, our Co-Founder and former Chief Business Development Officer in the amount of $250,000.
• The John Yozamp Note required monthly interest only payments at 10% per annum.
• The John Yozamp Note was converted into a convertible debenture in May 2021 which was subsequently converted into 236,498 shares of our Common Stock on October 29, 2021.
• On May 21, 2021, in exchange for his $20,000 investment, the Company issued a convertible debenture in the principal amount of $20,000 to Paul Shoun, our Co-Founder, President, Chief Operating Officer, and Chairman of the Board, which was converted into 17,325 shares of our Common Stock on October 29, 2021.

Stakeholder Impact

• Stockholders will be impacted by the potential reverse stock split, which could affect the stock price and trading liquidity.
• Stockholders will experience dilution in their ownership interests as a result of the potential issuance of shares of Common Stock upon exercise of the Series A and B Warrants.
• Employees and service providers may be impacted by changes in the stock price, which could affect the company's ability to attract and retain talent.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
• The Board of Directors will determine whether to implement the reverse stock split and authorized share reduction based on market conditions and the best interests of the company.
• The company will notify Series A Warrant holders of Stockholder Approval within two trading days of receipt.

Key Dates

Keywords

reverse stock split, authorized share reduction, proxy statement, annual meeting, warrants, Nasdaq, Expion360, stockholders